Your browser doesn't support javascript.
loading
Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury.
Van Campenhout, Raf; De Groof, Timo W M; Kadam, Prashant; Kwak, Brenda R; Muyldermans, Serge; Devoogdt, Nick; Vinken, Mathieu.
Afiliação
  • Van Campenhout R; Entity of In Vitro Toxicology and Dermato-Cosmetology, Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, 1090, Brussels, Belgium.
  • De Groof TWM; In Vivo Cellular and Molecular Imaging Laboratory, Department of Molecular Imaging, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
  • Kadam P; Entity of In Vitro Toxicology and Dermato-Cosmetology, Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, 1090, Brussels, Belgium.
  • Kwak BR; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, CH-1211, Geneva, Switzerland.
  • Muyldermans S; Geneva Center for Inflammation Research, Faculty of Medicine, University of Geneva, CH-1211, Geneva, Switzerland.
  • Devoogdt N; Laboratory of Cellular and Molecular Immunology, Bioengineering Sciences Department, Vrije Universiteit Brussel, 1050, Brussels, Belgium.
  • Vinken M; In Vivo Cellular and Molecular Imaging Laboratory, Department of Molecular Imaging, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
J Nanobiotechnology ; 21(1): 371, 2023 Oct 11.
Article em En | MEDLINE | ID: mdl-37821897

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / Hepatopatias Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / Hepatopatias Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica